Baxter International Takes the Initiative in Recalling Four IV SolutionsAugust 08, 2014
Baxter International Inc., a global leader in medical devices, pharmaceuticals and biotechnology advancements, initiated a voluntary recall of a batch of intravenous (IV) solutions which has been discovered to contain particulate matter identified as cellulosic fibers or plastic materials. The voluntary recall was preceded by four incidents of patient complaints citing visible particulate matters on the infusion pump system prior to drug administration.
The affected IV infusion products from Baxter include Sodium Chloride (NaCl) Injection and highly concentrated Potassium Chloride (KCl) Injection. Sodium Chloride Injection is parenteral solution intended for intravenous administration of water and electrolyte requirements. Potassium chloride injection is an intravenously administered injectable suitable for potassium replacement to reinforce nerve conduction and muscle contraction, as well as prevent cardiac arrhythmias. The recalled products were distributed globally to customers between February 2013 and June 2014. Click here to see a table of the affected products.
Particulate contamination in IV drugs might trigger adverse effects like chronic and/or acute inflammation, allergies, and other life-threatening complications. However, the adverse effects of infused particulate matter may vary according to the quantity infused into the patient, the particle size, the patient's underlying medical state, and an indication of a right-to-left cardiac shunt or the deviation of the blood flow pattern from its normal left-to-right circuit.
Being a leader in providing healthcare solutions for more than eight decades, Baxter urgently offered healthcare assistance to customers who filed the complaints and followed it with a voluntary recall. Consumers were also notified that unused recalled lots should be returned accordingly and unaffected lots of product are available for replacement. Furthermore, other adverse reactions experienced with the use of these IV solutions may be directly reported to the Food and Drug Administration (FDA) MedWatch Adverse Event Reporting Program.
Today’s healthcare facilities must invest on leading-edge infusion pump equipment and intravenous therapy solutions to ensure the delivery of quality and safe health care services to patients. AIV is a dedicated provider of IV pumps, replacement parts, system accessories, and repair services for most leading infusion pump brands in the market, including Baxter. Learn more about AIV’s full spectrum of IV pump products and services at www.aiv-inc.com/iv-infusion-pump-replacement-parts.html today.
About the Author
AIV CatalogRequest Your Printed or Electronic Copy Today!
Be Part of Our
Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.Get Biomed Resources
Why buy from AIV
AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.